Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody

OBJECTIVES: Effective antibody–drug conjugates (ADCs) provide potent targeted cancer therapies. CD83 is expressed on activated immune cells including B cells and is a therapeutic target for Hodgkin lymphoma. Our objective was to determine CD83 expression on non‐Hodgkin lymphoma (NHL) and its therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziduo, Abadir, Edward, Lee, Kenneth, Clarke, Candice, Bryant, Christian E, Cooper, Wendy, Pietersz, Geoffrey, Favaloro, James, Silveira, Pablo A, NJ Hart, Derek, Ju, Xinsheng, Clark, Georgina J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362189/
https://www.ncbi.nlm.nih.gov/pubmed/32685149
http://dx.doi.org/10.1002/cti2.1156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362189/
https://www.ncbi.nlm.nih.gov/pubmed/32685149
http://dx.doi.org/10.1002/cti2.1156

Ejemplares similares